drugset / Trial / NCT00002557

Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides

NCT00002557 ↗

Phase 2 Unknown 3 enrolled National Cancer Institute (NCI)
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of etoposide with or without doxorubicin and methotrexate in treating patients who have mycosis fungoides.

Timeline

Start
1993-06
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxorubicin Other / unclassified — —
Subject Etoposide Small molecule — Oral
Subject Methotrexate Small molecule — —
Background Leucovorin Small molecule — —

Indications